Southern Copper's price target has been cut to $83.50 by JPMorgan Chase & Co., from $84.00, keeping a neutral stance on the stock. Despite this downgrade, other analysts are more optimistic, with UBS ...

Dearborn Partners LLC recently reduced its stake in NVIDIA by 3.2%, selling 1,025 shares, leaving it with 31,306 shares valued at $4.2 million. Multiple hedge funds have also adjusted their NVIDIA ...

UBS Group recently cut Microsoft’s target price from $510 to $480, maintaining a “buy” rating. Other analysts have also weighed in, with some lowering their price targets while others keep their ...

Big-money investors, aka “whales,” have taken a cautiously bearish turn on Airbnb’s options, making more put trades than ...

Apple's price target was reduced by JPMorgan Chase from $270 to $245, despite their "overweight" rating. Analysts are clearly mixed on Apple’s future, as Tigress Financial raised their target to $300 ...

Analysts are playing financial ping-pong with The Cigna Group’s price target, but the net effect is positive. Truist ...

Christopher D’Ambrosio, a corporate VP at ADP, sold 478 shares for $140,120 while the stock hovered near a 52-week high. This ...

Cerity Partners gave Regeneron a small but mighty vote of confidence, upping their stake by 3.3% in the fourth quarter. They ...

Oppenheimer trimmed KLA’s price target from $850 to $700, joining a chorus of analysts adjusting expectations in the ...

Analysts can't seem to agree on Marsh & McLennan's stock direction, but one thing's clear—it’s making headlines. Keefe, ...

Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...

Truist Financial trimmed its price target from $120 to $113, but kept the "buy" label firmly in place. This move follows a ...